Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”Attending the International Society on Thrombosis and Haemostasis (ISTH) Congress is always one of the highlights of my year ISTH 2026, and I was especially excited to be in Paris, France this year.
I had the privilege of presenting our latest work on ADAMTS13/VWF dysregulation in sepsis on behalf of my graduate student, Olamilekan George.
Throughout my career, ISTH has played a transformative role by fostering an exceptional global network of colleagues, hosting a vibrant and scientifically outstanding congress, championing diversity and inclusivity, and providing awards and opportunities that enable early-career investigators to participate and grow.
The Society has created an environment where scientists at every stage can connect, collaborate, and thrive, and I am grateful to be part of this remarkable community.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients